IDEAYA Biosciences (IDYA) plans to raise $70 million in an initial public offering (IPO) on Thursday, May 23rd, IPO Scoop reports. The company will issue 5,000,000 shares at a price of $13.00-$15.00 per share.
The company has a market cap of $272.7 million.
J.P. Morgan, Citigroup and Jefferies acted as the underwriters for the IPO.
IDEAYA Biosciences provided the following description of their company for its IPO: ” We are an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Our approach integrates extensive capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies we are developing. We are applying these capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality – which represents an emerging class of precision medicine targets. “.
IDEAYA Biosciences was founded in 2015 and has 58 employees. The company is located at 7000 Shoreline Court, Suite 350, South San Francisco, CA 94080, US and can be reached via phone at (650) 443-6209 or on the web at http://www.ideayabio.com.
Receive News & Ratings for IDEAYA Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEAYA Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.